In conclusion, as clearly stated in recent studies, the diagnosis of ARMS requires a molecular confirmation, and Ap2β is a reliable immunohistochemical marker of t+ ARMS. This evidence concerns the gene TFAP2B and alveolar rhabdomyosarcoma.